프로톤 펌프 억제제(PPI) 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2034년)

Proton Pump Inhibitors (PPIs) Market - Scope of Report

TMR's report on the global proton pump inhibitors (PPIs) market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global proton pump inhibitors (PPIs) market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global proton pump inhibitors (PPIs) market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the proton pump inhibitors (PPIs) market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global proton pump inhibitors (PPIs) market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global proton pump inhibitors (PPIs) market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global proton pump inhibitors (PPIs) market.

The report delves into the competitive landscape of the global proton pump inhibitors (PPIs) market. Key players operating in the global proton pump inhibitors (PPIs) market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global proton pump inhibitors (PPIs) market profiled in this report.

Key Questions Answered in Global proton pump inhibitors (PPIs) Market Report:

• What is the sales/revenue generated by proton pump inhibitors (PPIs) across all regions during the forecast period?
• What are the opportunities in the global proton pump inhibitors (PPIs) market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Proton Pump Inhibitors (PPIs) Market - Research Objectives and Research Approach

The comprehensive report on the global proton pump inhibitors (PPIs) market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global proton pump inhibitors (PPIs) market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global proton pump inhibitors (PPIs) market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Proton Pump Inhibitors (PPIs) Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Proton Pump Inhibitors (PPIs) Market Analysis and Forecasts, 2020-2034
• 4.5. Porter's Five Force Analysis

5. Key Insights

• 5.1. Regulatory Scenario
• 5.2. Product Approval/Launches
• 5.3. Pipeline Analysis

6. Global Proton Pump Inhibitors (PPIs) Market Analysis and Forecasts, By Drug Type

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value Forecast By Drug Type, 2020-2034
  • 6.3.1. Omeprazole
  • 6.3.2. Pantoprazole
  • 6.3.3. Esomeprazole
  • 6.3.4. Lansoprazole
  • 6.3.5. Rabeprazole
  • 6.3.6. Others (Dexlansoprazole, etc.)
• 6.4. Market Attractiveness By Drug Type

7. Global Proton Pump Inhibitors (PPIs) Market Analysis and Forecasts, By Indication Type

• 7.1. Introduction & Definition
• 7.2. Key Findings / Developments
• 7.3. Market Value Forecast By Indication Type, 2020-2034
  • 7.3.1. Gastroesophageal Reflux Disease
  • 7.3.2. Peptic Ulcers
• 7.4. Market Attractiveness By Indication Type

8. Global Proton Pump Inhibitors (PPIs) Market Analysis and Forecasts, By End-user

• 8.1. Introduction & Definition
• 8.2. Key Findings / Developments
• 8.3. Market Value Forecast By End-user, 2020-2034
  • 8.3.1. Hospital Pharmacies
  • 8.3.2. Retail Pharmacies
  • 8.3.3. Online Pharmacies
• 8.4. Market Attractiveness By End-user

9. Global Proton Pump Inhibitors (PPIs) Market Analysis and Forecasts, By Region

• 9.1. Key Findings
• 9.2. Market Value Forecast By Region
  • 9.2.1. North America
  • 9.2.2. Europe
  • 9.2.3. Asia Pacific
  • 9.2.4. Latin America
  • 9.2.5. Middle East & Africa
• 9.3. Market Attractiveness By Country/Region

10. North America Proton Pump Inhibitors (PPIs) Market Analysis and Forecast

• 10.1. Introduction
  • 10.1.1. Key Findings
• 10.2. Market Value Forecast By Drug Type, 2020-2034
  • 10.2.1. Omeprazole
  • 10.2.2. Pantoprazole
  • 10.2.3. Esomeprazole
  • 10.2.4. Lansoprazole
  • 10.2.5. Rabeprazole
  • 10.2.6. Others (Dexlansoprazole, etc.)
• 10.3. Market Value Forecast By Indication Type, 2020-2034
  • 10.3.1. Gastroesophageal Reflux Disease
  • 10.3.2. Peptic Ulcers
• 10.4. Market Value Forecast By End-user, 2020-2034
  • 10.4.1. Hospital Pharmacies
  • 10.4.2. Retail Pharmacies
  • 10.4.3. Online Pharmacies
• 10.5. Market Value Forecast By, 2020-2034
• 10.6. Market Value Forecast By Country, 2020-2034
  • 10.6.1. U.S.
  • 10.6.2. Canada
• 10.7. Market Attractiveness Analysis
  • 10.7.1. By Drug Type
  • 10.7.2. By Indication Type
  • 10.7.3. By End-user
  • 10.7.4. By Country

11. Europe Proton Pump Inhibitors (PPIs) Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast By Drug Type, 2020-2034
  • 11.2.1. Omeprazole
  • 11.2.2. Pantoprazole
  • 11.2.3. Esomeprazole
  • 11.2.4. Lansoprazole
  • 11.2.5. Rabeprazole
  • 11.2.6. Others (Dexlansoprazole, etc.)
• 11.3. Market Value Forecast By Indication Type, 2020-2034
  • 11.3.1. Gastroesophageal Reflux Disease
  • 11.3.2. Peptic Ulcers
• 11.4. Market Value Forecast By End-user, 2020-2034
  • 11.4.1. Hospital Pharmacies
  • 11.4.2. Retail Pharmacies
  • 11.4.3. Online Pharmacies
• 11.5. Market Value Forecast By, 2020-2034
• 11.6. Market Value Forecast By Country/Sub-region, 2020-2034
  • 11.6.1. Germany
  • 11.6.2. U.K.
  • 11.6.3. France
  • 11.6.4. Italy
  • 11.6.5. Spain
  • 11.6.6. Rest of Europe
• 11.7. Market Attractiveness Analysis
  • 11.7.1. By Drug Type
  • 11.7.2. By Indication Type
  • 11.7.3. By End-user
  • 11.7.4. By Country/Sub-region

12. Asia Pacific Proton Pump Inhibitors (PPIs) Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast By Drug Type, 2020-2034
  • 12.2.1. Omeprazole
  • 12.2.2. Pantoprazole
  • 12.2.3. Esomeprazole
  • 12.2.4. Lansoprazole
  • 12.2.5. Rabeprazole
  • 12.2.6. Others (Dexlansoprazole, etc.)
• 12.3. Market Value Forecast By Indication Type, 2020-2034
  • 12.3.1. Gastroesophageal Reflux Disease
  • 12.3.2. Peptic Ulcers
• 12.4. Market Value Forecast By End-user, 2020-2034
  • 12.4.1. Hospital Pharmacies
  • 12.4.2. Retail Pharmacies
  • 12.4.3. Online Pharmacies
• 12.5. Market Value Forecast By, 2020-2034
• 12.6. Market Value Forecast By Country/Sub-region, 2020-2034
  • 12.6.1. China
  • 12.6.2. India
  • 12.6.3. Japan
  • 12.6.4. Australia & New Zealand
  • 12.6.5. Rest of Asia Pacific
• 12.7. Market Attractiveness Analysis
  • 12.7.1. By Drug Type
  • 12.7.2. By Indication Type
  • 12.7.3. By End-user
  • 12.7.4. By Country/Sub-region

13. Latin America Proton Pump Inhibitors (PPIs) Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast By Drug Type, 2020-2034
  • 13.2.1. Omeprazole
  • 13.2.2. Pantoprazole
  • 13.2.3. Esomeprazole
  • 13.2.4. Lansoprazole
  • 13.2.5. Rabeprazole
  • 13.2.6. Others (Dexlansoprazole, etc.)
• 13.3. Market Value Forecast By Indication Type, 2020-2034
  • 13.3.1. Gastroesophageal Reflux Disease
  • 13.3.2. Peptic Ulcers
• 13.4. Market Value Forecast By End-user, 2020-2034
  • 13.4.1. Hospital Pharmacies
  • 13.4.2. Retail Pharmacies
  • 13.4.3. Online Pharmacies
• 13.5. Market Value Forecast By, 2020-2034
• 13.6. Market Value Forecast By Country/Sub-region, 2020-2034
  • 13.6.1. Brazil
  • 13.6.2. Mexico
  • 13.6.3. Rest of Latin America
• 13.7. Market Attractiveness Analysis
  • 13.7.1. By Drug Type
  • 13.7.2. By Indication Type
  • 13.7.3. By End-user
  • 13.7.4. By Country/Sub-region

14. Middle East & Africa Proton Pump Inhibitors (PPIs) Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast By Drug Type, 2020-2034
  • 14.2.1. Omeprazole
  • 14.2.2. Pantoprazole
  • 14.2.3. Esomeprazole
  • 14.2.4. Lansoprazole
  • 14.2.5. Rabeprazole
  • 14.2.6. Others (Dexlansoprazole, etc.)
• 14.3. Market Value Forecast By Indication Type, 2020-2034
  • 14.3.1. Gastroesophageal Reflux Disease
  • 14.3.2. Peptic Ulcers
• 14.4. Market Value Forecast By End-user, 2020-2034
  • 14.4.1. Hospital Pharmacies
  • 14.4.2. Retail Pharmacies
  • 14.4.3. Online Pharmacies
• 14.5. Market Value Forecast By, 2020-2034
• 14.6. Market Value Forecast By Country, 2020-2034
  • 14.6.1. GCC
  • 14.6.2. South Africa
  • 14.6.3. Rest of Middle East & Africa
• 14.7. Market Attractiveness Analysis
  • 14.7.1. By Drug Type
  • 14.7.2. By Indication Type
  • 14.7.3. By End-user
  • 14.7.4. By Country/Sub-region

15. Competition Landscape

• 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 15.2. Company Profiles
  • 15.2.1. Pfizer
    • 15.2.1.1. Company Overview
    • 15.2.1.2. Financial Overview
    • 15.2.1.3. Product Portfolio
    • 15.2.1.4. Business Strategies
    • 15.2.1.5. Recent Developments
  • 15.2.2. Teva Pharmaceutical Industries Ltd.
    • 15.2.2.1. Company Overview
    • 15.2.2.2. Financial Overview
    • 15.2.2.3. Product Portfolio
    • 15.2.2.4. Business Strategies
    • 15.2.2.5. Recent Developments
  • 15.2.3. LUPIN Limited
    • 15.2.3.1. Company Overview
    • 15.2.3.2. Financial Overview
    • 15.2.3.3. Product Portfolio
    • 15.2.3.4. Business Strategies
    • 15.2.3.5. Recent Developments
  • 15.2.4. Amneal Pharmaceuticals LLC
    • 15.2.4.1. Company Overview
    • 15.2.4.2. Financial Overview
    • 15.2.4.3. Product Portfolio
    • 15.2.4.4. Business Strategies
    • 15.2.4.5. Recent Developments
  • 15.2.5. Zydus Cadila
    • 15.2.5.1. Company Overview
    • 15.2.5.2. Financial Overview
    • 15.2.5.3. Product Portfolio
    • 15.2.5.4. Business Strategies
    • 15.2.5.5. Recent Developments
  • 15.2.6. Sun Pharmaceutical Industries Ltd.
    • 15.2.6.1. Company Overview
    • 15.2.6.2. Financial Overview
    • 15.2.6.3. Product Portfolio
    • 15.2.6.4. Business Strategies
    • 15.2.6.5. Recent Developments
  • 15.2.7. Alembic Pharmaceuticals Limited
    • 15.2.7.1. Company Overview
    • 15.2.7.2. Financial Overview
    • 15.2.7.3. Product Portfolio
    • 15.2.7.4. Business Strategies
    • 15.2.7.5. Recent Developments
  • 15.2.8. Sanofi S.A.
    • 15.2.8.1. Company Overview
    • 15.2.8.2. Financial Overview
    • 15.2.8.3. Product Portfolio
    • 15.2.8.4. Business Strategies
    • 15.2.8.5. Recent Developments
  • 15.2.9. AstraZeneca
    • 15.2.9.1. Company Overview
    • 15.2.9.2. Financial Overview
    • 15.2.9.3. Product Portfolio
    • 15.2.9.4. Business Strategies
    • 15.2.9.5. Recent Developments